1/21/2013

Lonza to Evaluate BaroFold’s Protein Refolding Technology

11/13/2012

Boehringer Ingelheim and BaroFold Announce Strategic Agreement on PreEMT™ High Pressure Protein Refolding Technology

11/13/2012

Nuron Biotech Completes Enrollment of a Pivotal Phase 3 Study for Proprietary Recombinant Human Interferon Beta-1b (NU100) in Relapsing Remitting Multiple Sclerosis

2/11/2011

BaroFold’s PreEMT Technology Scaled for Phase 3 Clinical Production

05/17/2010

BaroFold Grants Exclusive License for Interferon Beta Products Developed Using PreEMT™ Technology to Nuron Biotech